1-9 of 9
Keywords: UFT
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1993) 50 (4): 209–213.
Published Online: 26 June 2009
...Mitsuaki Suzuki; Ichiro Aida; Isao Sekiguchi; Taro Tamada; Sumiaki Tsuru Effects of cisplatin and etoposide chemotherapy and/or continuous administration of oral anticancer agent UFT following the initial chemotherapy with cisplatin and etoposide on the tumor recurrence rate were studied...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2009) 76 (5): 338–341.
Published Online: 23 March 2009
.../II trial was performed to evaluate the efficacy and safety of continuous infusion of irinotecan combined with UFT plus leucovorin (LV) for metastatic colorectal cancer. Methods: Escalating doses of irinotecan (90–110 mg/m 2 ) were administered by 24-hour infusion on day 1. UFT 300 mg/m 2 /day and LV...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2009) 76 (5): 301–310.
Published Online: 20 March 2009
...Jaafar Bennouna; Mark Saunders; Jean-Yves Douillard 5-Fluorouracil (5-FU) has been the most widely used chemotherapeutic agent for metastatic colorectal cancer (mCRC) and 5-FU combination therapy improves efficacy compared with monotherapy. The oral fluoropyrimidine UFT (tegafur-uracil...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2008) 72 (5-6): 267–273.
Published Online: 11 January 2008
... in about 50% of patients during the 6-month FOLFOX4 regimen, and the frequent need for hospitalization, alternative regimens may be required. We aimed to determine whether a ‘maintenance’ therapy with oral UFT (uracil-tegafur) in patients responding to FOLFOX4 is able to maintain the response and improve...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2004) 66 (1): 1–17.
Published Online: 19 March 2004
...Gunnar Folprecht; Claus-Henning Köhne New drugs improved efficacy or convenience of treatment in metastatic colorectal cancer. The oral fluoropyrimidines capecitabine and UFT are less toxic but equally efficacious relative to intravenous bolus 5-fluorouracil (5-FU)/folinic acid (FA). These agents...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2003) 64 (2): 146–153.
Published Online: 03 February 2003
...Fujio Kasumi; Masataka Yoshimoto; Junichi Uchino; Rikiya Abe; Yasuo Nomura; Keizo Sugimachi; Hiroaki Nakazato; Osahiko Abe Meta-analysis of 5 studies on postoperative breast cancer cases (2 studies on surgery alone vs. tegafur plus uracil (UFT) and 3 studies on tamoxifen (TAM) alone vs. TAM + UFT...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2000) 60 (1): 49–54.
Published Online: 28 December 2000
...K. Nishimura; N. Nonomura; Y. Ono; M. Nozawa; T. Fukui; Y. Harada; T. Imazu; N. Takaha; H. Sugao; T. Miki; A. Okuyama Objective: To evaluate the clinical usefulness of an oral combination of cyclophosphamide, uracil plus tegafur (UFT) and estramustine in the treatment of patients with hormone...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1999) 57 (Suppl. 1): 2–8.
Published Online: 21 July 1999
... Colon cancer Fluoropyrimidines 5-FU UFT S-1 Xeloda ® (capecitabine) Emitefur Eniluracil Oral chemotherapy 5-FU has been studied in several different dosing regimens, including a daily bolus schedule for five consecutive days, weekly bolus schedules and continuous infusions extending...